bpc-157 fda category 2 compounding bpc 157 news bulk drug substances list HHS Secretary RFK Jr. just dropped major news: the FDA is removing 12 peptides from its restrictive Category 2 list — reversing the 2023 FDA Peptide Category Update: Clarifying

It suppresses appetite and increases energy expenditure, without the crash of stimulant-based fat burners

Sermorelin acetate

Only a small percentage of a standard oral dose is absorbed through this active pathway, and that number drops further when digestion is impaired

One of the arguments for this is that NAD is a large molecule that's not as easily absorbed in the body, so taking smaller compounds and allowing the body to convert them once they're absorbed might actually raise be more efficient in terms of how much NAD+ you get but there's still no definitive answer to which method works best, so what's the difference in dosages if you're taking an NAD precursor